EB-2 (NIW) for French Nationals

USCIS I-140 petition data for France nationals (FY2025 Q4 (Jul-Sep 2025)).

42 I-140 petitions 9 approved #24 by volume
Subcategory:

USCIS I-140 Data

France I-140 Petition Statistics

USCIS EB-2 (NIW) petition data for France nationals. FY2025 Q4 (Jul-Sep 2025).

I-140 Receipts

42

0.2% of all

I-140 Approvals

9

of 5,929 total

Volume Rank

#24

by I-140 receipts

Source: USCIS I-140 Performance Data, FY2025 Q4 (Jul-Sep 2025). Receipts and approvals for the reporting quarter.

Priority Date Tracker

Final Action Date

Oct 2024

ROW Final Action

Oct 2024

Source: DOS Visa Bulletin (2026-03)

Wait Time Estimator

Estimate Your Green Card Timeline

Enter your priority date and country to get a personalized estimate based on average DOS Final Action Date advancement over the last 12 months.

EB-2 (incl. NIW)

Sources: I-140/I-485 ranges from USCIS Processing Times, backlog advancement averaged over last 12 DOS Visa Bulletins. Estimates only.

Find French EB-2 (NIW) Cases

Browse real petition decisions and case studies from France, or join the waitlist to get notified when personalized case matching launches.

Country Comparison

USCIS I-140 data, FY2025 Q4 (Jul-Sep 2025)

CountryReceiptsApprovals
Grand Total 13,9832,968
China 2,330715
India 1,685426
France (current)429
Case Data Insights

We analyzed 4 publicly available EB-2 (NIW) petition decisions involving France nationals. Of these, 100% were approved or sustained. These cases span 2 industries and 4 job titles. Explore the charts below to see how decision outcomes have trended over time and which industries and roles have the highest success rates.

Decision Trends

0232022-042022-082022-122023-042023-082023-122024-042024-082024-122025-04
Approved
Remanded
Denied

Top Industries

Research and Development 2
Engineering 1

Top Job Titles

Data Scientist 1
Research Fellow 1
Research Scientist 1
Researcher 1

Policy Updates

General View all
Mar 2026 info Visa Bulletin

Visa Bulletin Update: EB-2 (2026-03)

The Department of State updated EB-2 Final Action Dates in the 2026-03 Visa Bulletin: - India: moved from 2013-07-15 to 2013-09-15 - Philippines: moved from 2024-04-01 to 2024-10-15 - Mexico: moved from 2024-04-01 to 2024-10-15 - Rest of World: moved from 2024-04-01 to 2024-10-15 This may allow additional applicants to proceed with their petitions.

advancementeb-2final-action-datepriority-date
Feb 2026 info Executive Order
Protecting the National Security and Welfare of the United States and its Citizens from Criminal Actors and Other Public Safety Threats

The policy directs DHS to maximize its use of criminal history record information (CHRI) for screening and vetting missions. This includes reciprocal data sharing with foreign governments, which will likely be utilized during the adjudication of EB-2 visas and National Interest Waivers.

vettingbackground checkssecurity screeningNIW
Jan 2026 warning USCIS Alert
USCIS to Increase Premium Processing Fees

The fee for Form I-907 is being adjusted upwards, impacting EB-2 petitioners who utilize expedited processing. This change is part of a broader USCIS effort to adjust fees for inflation and maintain service levels.

premium processinguscis feesNIWform i-907
Jan 2026 warning USCIS Memo
DHS Launches Landmark USCIS Fraud Investigation in Minnesota

The investigation focuses on identifying fraudulent activities within USCIS filings in the Minnesota region. EB-2 applicants may experience heightened vetting procedures, including more frequent Requests for Evidence (RFEs) and audits of employer credentials. This initiative is part of a broader DHS effort to ensure the integrity of employment-based immigration programs.

fraud investigationcomplianceUSCISDHS
Jan 2026 info Visa Bulletin

Visa Bulletin Update: EB-2 (2026-01)

The Department of State updated EB-2 Final Action Dates in the 2026-01 Visa Bulletin: - India: moved from 2013-05-15 to 2013-07-15 - China: moved from 2021-06-01 to 2021-09-01 - Philippines: moved from 2024-02-01 to 2024-04-01 - Mexico: moved from 2024-02-01 to 2024-04-01 - Rest of World: moved from 2024-02-01 to 2024-04-01 This may allow additional applicants to proceed with their petitions.

advancementeb-2final-action-datepriority-date

Frequently Asked Questions

At a Glance

USCIS Official Data

I-140 Receipts 42
I-140 Rank #24 of 191

Scraped Case Data

Decisions 4
Success Rate 100%
Country Share 0.1%
Approved / Sustained 4
Denied / Dismissed 0
Top Industry Research and Development
Top Job Title Data Scientist

Recent Decisions

View all

Research Scientist

Research and Development · France

WeGreened approved
Maryland 305 days 2025-04-03
The petitioner proposes to develop protective and regenerative strategies to treat hearing loss using electrophysiological and high-resolution imaging methods. His work specifically focuses on repairing ribbon synapses after acoustic trauma and regulating auditory nerve fiber synaptic transmission to restore hearing function.
View Case

Researcher

Engineering · France

WeGreened approved
62 days 2023-03-28
The petitioner proposes to continue research on extending current imaging modalities to support the development of multi-modal imaging for biomedical purposes. This work includes hyperspectral imaging in complex media and fast-tunable spatial light modulation for imaging and display applications.
View Case

Data Scientist

Others · France

WeGreened approved
North Carolina 17 days 2023-03-13
The petitioner proposes to develop advanced machine learning algorithms using large, complex genomics datasets to improve disease diagnostics and solve complex problems in mathematical bioinformatics. His work specifically focuses on enhancing early cancer detection through next-generation sequencing and applying differential equations to predict economic trends.
View Case

Research Fellow

Research and Development · France

WeGreened approved
Maryland 762 days 2022-04-02
The petitioner proposes to analyze the connection between vitamins and diseases, including cancer, diabetes, and sickle cell anemia. The work focuses on improving therapeutic interventions and treatment methods through a novel lens in cellular biology.
View Case